Results 141 to 150 of about 26,260 (297)
Objective Cerebral ischemic stroke causes neuronal oxygen/energy deprivation, disrupting mitochondrial function including reduced membrane potential and bioenergetics, exacerbating neuronal injury. Mitochondrial defects are, therefore, a central neuropathological node and potential therapeutic target.
Ning Bian +9 more
wiley +1 more source
Experience with systemic or selective local administration of thrombolytic agents in pediatric ischemic stroke is limited to sporadic case reports, since patients of age less than 18 years were systematically excluded from randomised controlled trials ...
Abanses, Juan Carlos +6 more
core
Prevalence and Risk Factors for Cerebral Microbleeds in Chinese Patients With Acute Ischemic Stroke
Approximately half of the patients with AIS exhibited CMBs, particularly those classified under LAA and SVD subtypes. Hypertension and severe WMH were independently associated with CMB presence. Distinct clinical profiles were observed based on CMB burden and location.
Ruiming Zhu +5 more
wiley +1 more source
The CHG index, derived from total cholesterol, high‐density lipoprotein, and fasting blood glucose, was associated with 90‐day functional outcomes after acute ischemic stroke. ABSTRACT Background: Acute ischemic stroke (AIS) is a major cause of global disability and mortality.
Xinyue Yuan +5 more
wiley +1 more source
Background. Percutaneous thrombolysis has become an accepted treatment of thrombosed haemodialysis grafts. Several devices have been developed for mechanical thrombolysis, which macerate the clot using different mechanisms such as aspiration and ...
Buskens, E +6 more
core +1 more source
Reperfusion by Combined Thrombolysis and Mechanical Thrombectomy in Acute Stroke: Effect of Collateralization, Mismatch, and Time to and Grade of Recanalization on Clinical and Tissue Outcome [PDF]
Volker Heßelmann +10 more
openalex +1 more source
Graphical representation of the comparative efficacy and safety of intravenous tirofiban for acute ischemic stroke in randomized controlled trials. ABSTRACT Background: Tirofiban is a GP IIb/IIIa inhibitor, an anti‐platelet drug that is used in ischemic stroke or acute coronary syndromes.
Dorothy Lim Bullecer +12 more
wiley +1 more source
A Case Report on Meningitis Complicated by Acute Ischemic Stroke and Failed Thrombolysis
ABSTRACT Ischemic stroke is one of the rare but grave complications of meningitis with poor outcomes and long‐term sequelae, and the role of thrombolysis with infection‐related stroke remains uncertain. This case report documents a 52‐year‐old man presented with fever, headache, vomiting, and altered sensorium, and on examination he had neck rigidity ...
Sonam Dema, Dechen Choden, Sonam Wangmo
wiley +1 more source
Successful pharmaco-mechanical treatment of a subtotally occluded venous bypass graft in a patient presenting with acute coronary syndrome: a case report and review of the current literature on the role of local thrombolysis [PDF]
Matthias Renker +3 more
openalex +1 more source

